Rong Yuan

ORCID: 0009-0005-6159-8063
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Circular RNAs in diseases
  • Retinopathy of Prematurity Studies
  • Retinal Development and Disorders
  • Cardiac Imaging and Diagnostics
  • Cancer-related gene regulation
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cerebrovascular and Carotid Artery Diseases
  • Phytochemicals and Antioxidant Activities
  • Herpesvirus Infections and Treatments
  • Medicinal Plant Pharmacodynamics Research
  • Mitochondrial Function and Pathology
  • Photoreceptor and optogenetics research
  • Cardiovascular Health and Disease Prevention
  • Cardiovascular Function and Risk Factors
  • Orthopedic Surgery and Rehabilitation
  • Natural Antidiabetic Agents Studies
  • RNA and protein synthesis mechanisms
  • RNA Research and Splicing
  • Metabolomics and Mass Spectrometry Studies
  • Peripheral Nerve Disorders
  • Advanced Proteomics Techniques and Applications

Hunan University of Traditional Chinese Medicine
2024

Peking University
2024

Peking University Third Hospital
2024

Xiyuan Hospital
2022-2024

Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2024

National Clinical Research Center for Digestive Diseases
2024

University of Alabama at Birmingham
2019

Versiti Blood Center of Wisconsin
2019

Chengdu Women's and Children's Central Hospital
2011

This study aimed to compare the intercostal nerve block (ICNB) and thoracic paravertebral (TPVB) for acute herpes zoster-associated pain (ZAP) possible prophylaxis post-herpetic neuralgia (PHN).

10.3344/kjp.24111 article EN cc-by-nc The Korean journal of pain 2024-09-30

This study aimed to explore the intervention effect of Chuanxiong-Chishao herb pair(CX-CS) on a myocardial infarction-atherosclerosis(MI-AS) mouse model and investigate its expression profile circular RNAs(circRNAs)/long non-coding RNAs(lncRNAs) in ischemic myocardium aorta. Sixty male ApoE~(-/-) mice were randomly assigned group, high-, medium-, low-dose CX-CS groups(7.8, 3.9, 1.95 g·kg~(-1)), positive drug group(metoprolol 26 mg·kg~(-1) simvastatin 5.2 mg·kg~(-1)), with 12 each group. Male...

10.19540/j.cnki.cjcmm.20230306.703 article EN PubMed 2023-07-01

Objective: The aim of this study was to investigate different carotid plaque types and their correlations with the risk factors for myocardial infarction (MI) in patients atherosclerosis (CA). Methods: A total 557 CA were enrolled, information on general data, artery types, combinations, factors, disease diagnoses retrospectively analyzed. Univariate multivariate logistic regression analyses employed identify factors. Results: Hard closely related B-type natriuretic peptide (BNP)...

10.1097/imna-d-24-00004 article EN Integrative Medicine in Nephrology and Andrology 2024-08-21

Coronary microvascular dysfunction (CMD) represents a principal etiological factor in ischemic heart disease. Nonetheless, considerable subset of CMD patients experiences diagnostic delays attributable to the inadequacy current methodologies; which turn results deferred therapeutic interventions and elevated mortality rates. This study seeks elucidate distinct metabolic profile associated with rat models identify specific markers that could enhance accuracy for CMD. In this study, 18 Wistar...

10.3390/biom14101305 article EN cc-by Biomolecules 2024-10-16

Supplementary Figures and Tables from Epidermal Growth Factor Receptor PTEN Modulate Tissue Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity

10.1158/0008-5472.22381037.v1 preprint EN cc-by 2023-03-30

<div>Abstract<p>Hypoxia and necrosis are fundamental features of glioblastoma (GBM) their emergence is critical for the rapid biological progression this fatal tumor; yet, underlying mechanisms poorly understood. We have suggested that vaso-occlusion following intravascular thrombosis could initiate or propagate hypoxia in GBM. Tissue factor (TF), main cellular initiator coagulation, overexpressed GBMs likely favors a thrombotic microenvironment. <i>Epidermal growth...

10.1158/0008-5472.c.6499739.v1 preprint EN 2023-03-30

Supplementary Figures and Tables from Epidermal Growth Factor Receptor PTEN Modulate Tissue Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity

10.1158/0008-5472.22381037 preprint EN cc-by 2023-03-30

<div>Abstract<p>Hypoxia and necrosis are fundamental features of glioblastoma (GBM) their emergence is critical for the rapid biological progression this fatal tumor; yet, underlying mechanisms poorly understood. We have suggested that vaso-occlusion following intravascular thrombosis could initiate or propagate hypoxia in GBM. Tissue factor (TF), main cellular initiator coagulation, overexpressed GBMs likely favors a thrombotic microenvironment. <i>Epidermal growth...

10.1158/0008-5472.c.6499739 preprint EN 2023-03-30

Many studies have been limited to using in vitro cellular assays and whole tissues or isolating of specific cell types from animals for analysis transcriptome gene expression by qPCR RNA sequencing. Comprehensive complex organs will be critical understand molecular mechanisms which genes are regulated their association with tissue homeostasis organ functions. In this article, we demonstrate the methodology isolation ribosome-bound directly vivo vascular endothelia animal lungs as an example....

10.3791/59624-v article EN Journal of Visualized Experiments 2019-05-25

This study aims to investigate the effects and underlying mechanism of Huangqi Shengmai Decoction(HQSMD) in treatment fatigue myocardial injury a joint rat model. Wistar rats were assigned into 4 groups: sham, model, diltiazem hydrochloride(positive control), HQSMD. The model was established by 14-day exhausted swimming followed high ligation left anterior descending coronary artery. sham group underwent operation without artery or swimming. Since fourth day after ligation, continued...

10.19540/j.cnki.cjcmm.20220325.702 article EN PubMed 2022-10-01
Coming Soon ...